1. Home
  2. CHWM vs ARCT Comparison

CHWM vs ARCT Comparison

Compare CHWM & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chilwa Minerals Limited American Depository Shares

CHWM

Chilwa Minerals Limited American Depository Shares

N/A

Current Price

$2.46

Market Cap

293.8M

Sector

N/A

ML Signal

N/A

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

N/A

Current Price

$7.41

Market Cap

293.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHWM
ARCT
Founded
N/A
2013
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.8M
293.9M
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
CHWM
ARCT
Price
$2.46
$7.41
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
★ $23.70
AVG Volume (30 Days)
8.4K
★ 608.0K
Earning Date
N/A
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.00
EPS
★ N/A
N/A
Revenue
N/A
★ $82,031,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.00
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.66
$5.50
52 Week High
$5.75
$17.96

Technical Indicators

Market Signals
Indicator
CHWM
ARCT
Relative Strength Index (RSI) 32.45 32.75
Support Level N/A $6.45
Resistance Level $5.63 $8.54
Average True Range (ATR) 0.53 0.90
MACD -0.12 -0.13
Stochastic Oscillator 25.18 2.37

Price Performance

Historical Comparison
CHWM
ARCT

About CHWM Chilwa Minerals Limited American Depository Shares

Chilwa Minerals Ltd is engaged in mineral exploration and evaluation at the Chilwa Critical Minerals Project (heavy mineral sands, rare earth elements niobium on the shores of Lake Chilwa in southern Malawi.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: